KROPZ PLC

Capital/Financing Update • Aug 18, 2023

National Storage Mechanism | Additional information

RNS Number : 8188J

Kropz PLC

18 August 2023

18 August 2023

Kropz Plc

("Kropz" or the "Company")

Drawdown on Bridge Loan Facilities

Kropz Plc (AIM: KRPZ), an emerging African phosphate producer and developer, announced on 14 March 2023 that it had entered into new bridge loan facilities of ZAR 285 million (the "Loan") with its major shareholder, the ARC Fund, to meet immediate cash requirements at Kropz Elandsfontein (Pty) Ltd.

The first draw down on the Loan for an amount of ZAR 25 million was made on 14 March 2023, a second draw down on the Loan for an amount of ZAR 90 million was made on 28 March 2023, a third drawdown was made for an amount of ZAR 30 million on 25 April 2023, a fourth draw down on the Loan for an amount of ZAR 80 million was made on 23 June 2023 and a fifth draw down request for an amount of ZAR 60 million was made today.  The Loan is now drawn down in full.

For further information visit www.kropz.com or contact:

Kropz Plc	Via Tavistock
Louis Loubser (CEO)	+44 (0) 207 920 3150
Grant Thornton UK LLP	Nominated Adviser
Samantha Harrison Harrison Clarke Ciara Donnelly	+44 (0) 20 7383 5100
Hannam & Partners	Broker
Andrew Chubb Ernest Bell	+44 (0) 20 7907 8500
Tavistock	Financial PR & IR (UK)
Nick Elwes Jos Simson Emily Moss	+44 (0) 207 920 3150 kropz@tavistock.co.uk
R&A Strategic Communications	PR (South Africa)
Charmane Russell Marion Brower	+27 (0) 11 880 3924 charmane@rasc.co.za  marion@rasc.co.za

About Kropz Plc

Kropz is an emerging African phosphate producer and developer with projects in South Africa and in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCSFAFEAEDSEFA